Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, January 23, 2017

Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium



 Pleiotropic: Producing or having multiple effects from a single gene
                      ~~~~~~~~~~~~
abstract:
Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium | Cancer Epidemiology, Biomarkers & Prevention
 

Background: Epigenetic disturbances are crucial in cancer initiation, potentially with pleiotropic effects, and may be influenced by the genetic background.
Methods: In a subsets (ASSET) meta-analytic approach, we investigated associations of genetic variants related to epigenetic mechanisms with risks of breast, lung, colorectal, ovarian and prostate carcinomas using 51,724 cases and 52,001 controls. False-discovery-rate corrected p-values (q-values < 0.05) were considered statistically significant.
Results: Among 162,887 imputed or genotyped variants in 555 candidate genes, SNPs in eight genes were associated with risk of more than one cancer type. For example, variants in BABAM1 were confirmed as a susceptibility locus for squamous cell lung, overall breast, ER-negative breast, overall prostate, overall and serous ovarian cancer; the most significant variant was rs4808076 (odds ratio (OR)=1.14, 95% confidence interval (CI)=1.10-1.19, q=6.87*10-5). DPF1 rs12611084 was inversely associated with ER-negative breast, endometrioid ovarian, overall and aggressive prostate cancer risk (OR=0.93, 95% CI=0.91-0.96, q=0.005). Variants in L3MBTL3 were associated with colorectal, overall breast, estrogen receptor (ER)-negative breast, clear cell ovarian, and overall and aggressive prostate cancer risk (e.g. rs9388766: OR=1.06, 95% CI=1.03-1.08, q= 0.02). Variants in TET2 were significantly associated with overall breast, overall prostate, overall ovarian and endometrioid ovarian cancer risk, rs62331150 showing bidirectional effects.
Analyses of sub-pathways did not reveal gene subsets that contributed disproportionately to susceptibility.
Conclusion: Functional and correlative studies are now needed to elucidate the potential links between germline genotype, epigenetic function, and cancer etiology. Impact: This approach provides novel insight into possible pleiotropic effects of genes involved in epigenetic processes.

0 comments :

Post a Comment

Your comments?